| |
DISTINGUISHED PRESENTERS
Click on the links below to view the speakers for each track, symposia or session.
|
| |
|
|
 |
Keith James, Ph.D.
Vice President
& Site Head
Pfizer, La Jolla |
 |
David Nicholson, Ph.D.
Senior Vice President
Global Project Management
Schering Plough |
 |
Johan Luthman
Global Head
Exploratory Medicine Neurology
MerckSerono International |
|
 |
John Doll
Commissioner of Patents
United States Patent & Trademark Office |
 |
Ashraf Hanna
Vice President
Alliance Management &Portfolio Planning
Genentech |
Back to Top
|
| |
|
|
|
Juan Almagro
Johnson & Johnson
Matthias Birkhoff
Pfeiffer Group
Larry Brown
Chief Technology Officer
Baxter BioScience
Partha Chowhury
Medimmune, Inc.
Luc Desnoyers
Genentech, Inc.
Patrizia Fanara
Director of Neurodegenerative Diseases
Kinemed, Inc.
Hideki Garren, M.D., Ph.D.
Co-Founder & Vice President of Research
Bayhill Therapeutics, Inc.
Markus Hilleringmann
Novartis Vaccines & Diagnostics
Chris Holmes
Senior Director, Chemistry
Affymax, Inc.
|
David King
Medarex
Lotte Bjerre Knudsen
Diabetes Biology & Pharmacology Mgt.
Novo Nordisk A/S
Brian MacDonald
CEO
Zelos Pharmaceuticals
Edward Maggio
President & CEO
Aegis Therapeutics LLC
Christopher Rhodes
Senior Director, Drug Delivery
Amylin Pharmaceuticals
Ronald Rooke
Transgene
Jaymin C. Shah
Research Formulations group
Pfizer, Inc.
Indresh Srivastava
Novartis
Jean-Philliipe Stephan
Genentech, Inc.
Back to Top
|
| |
|
|
Christophe Antczak
Senior Research Scientist
HTS Core Facility
Memorial Sloan-Kettering Cancer Center
Luigi Aurisicchio
Merck & Co.
Adrian Bot
Senior Director
Scientific Management
MannKind Corporation
Paul L. Domanico
President
Domanico Consulting, LLC
James Dykens
Pfizer Global R&D
Patrizia Fanara
Director of Neurodegenerative Diseases
Kinemed
John Ferbas
Associate Director, Clinical Immunology
Amgen
Boris Ferger
Head of Preclinical In Vivo Parkinson's Disease Research
Boehringer Ingelheim Pharma GmbH
|
Ken Kornman
Interleukin Genetics
Frank Kramer
Bayer Healthcare
Thomas Lee
Eli Lilly & Co.
Shane Marine
Merck & Co.
Paul Nioi
Schering-Plough Research Institute
Christopher L. Shaffer
Pharmacokinetics, Pharmacodynamics
and Metabolism
Pfizer Global R&D
Christopher Winrow
Merck Research Laboratories
Hequn Yin
Novartis
Ming Yu
Bristol-Myers Squibb
Back to Top
|
| |
|
|
Gal Cohen
Director, Corporate Business Development & Alliance Management
Nektar Therapeutics
Michael Crowley
Associate Director,
Business Development
Genentech, Inc.
Jack J. Florio
Partner
Tech Coast Angels
Channing Hamlet
Cabrillo Investors
Timothy Herpin
Director, Cardiovascular &
Metabolic Disease Licensing
Bristol-Myers Squibb
Nils Peter Debus
Senior Director,
Global Business Development & Licensing
Office of Technology USA
Bayer Healthcare
Aron Knickerbocker
Senior Director, Business Development Genentech, Inc.
Holger Lehman
Director, Drug Discovery
Schering-Plough Research Institute |
Nick Lemon
Corporate Business Development
Eli Lilly & Co.
Jane Moores
Licensing Office
UCSD
Nayan Nanavati
Vice President
PAREXEL International Corp.
Paul Resnick
Senior Director of Strategic Alliances
Pfizer, Inc.
Sameeh Salama
Vice President, Business Development
NAEJA Pharmaceuticals
Alexander Schuth
Finance Manager
Genentech, Inc.
John Wehrli
Partner
Latham & Watkins
Yael Weiss
Director, Licensing & External Research
Merck & Co.
Back to Top
|
| |
|
|
David Andrews
Associate Director
Cancer & Infection Chemistry
AstraZeneca
Hans Bitter
Medicinal Chemistry
Roche
Jean-Francois Bonfanti
Medicinal Chemistry
Johnson & Johnson
Hinnerk Boriss
CEO
Sovicell
Maxwell Cummings
Tibotec
Allen J. Duplantier
Pfizer Global R&D
Istvan Enyedy
Biogen Idec
Fabrizio Giordanetto
AstraZeneca
Gilles Hanton
Toxicology & Comparative Medicine
Pfizer, Inc. |
Rama Kondru
Computational Chemistry Group
Roche
Matt Patricelli, Ph.D.
Director of Technology
ActivX
Paul Richardson
Advanced Technologies
Abbott Laboratories
Goetz Schlotterbeck
Scientific Specialist
Metabolic Profiling and Biomarkers
Roche
Walter Strapps
Merck & Co.
Jeff Wiseman
VP, Technology & Corporate Development
Locus Pharmaceuticals
Josh Xiao
Amgen, Inc.
Igor Mochalkin
EMS - Computational Sciences
Pfizer, Inc.
Back to Top
|
| |
|
|
Heather Arnett
Amgen, Inc.
Andrew R. Blight
Chief Scientific Officer
Acorda Therapeutics, Inc.
Mark Frattini
Assistant Member, Dept of Medicine
Memorial Sloan-Kettering Cancer Center
Kevin Foley
Synta Pharmaceuticals Corp.
Anne Fourie
Johnson & Johnson PRD
Edward K. Han
Cancer Research
Abbott Laboratories
Rao Kalla
CV Therapeutics, Inc.
John H. Kehne
Executive Director
Neurogen Corporation
Randolf Kerschbaumer
Manager Molecular Biology
Baxter BioScience
Roman Kischel
Director of Immunotherapy
Micromet AG
|
Xiangdong Liu
Incyte Corporation
Radmila Micanovic
Eli Lilly & Co.
William E. Munger
Executive Director
Technology & Program Management
Curis
Gary A. Piazza
Program Director
Southern Research Molecular Libraries Screening Center
Southern Research Institute
Christian Rohlff
Chief Executive Officer
Oxford Genome Sciences
Joel E. Tocker
Director of Research
Amgen, Inc.
Danzhou Yang
Dept of Pharmacology & Toxicology
College of Pharmacy
University of Arizona
Qi-Zhuang Ye
Associate Professor
Dept of Biochemistry & Molecular Biology
Indiana University School of Medicine
Back to Top
|
| |
|
|
Michael Bolger
Founding Scientist
Director of Life Sciences
Simulations Plus
Ralf Glatthar
Project Team Leader
Novortis
Serge Guzy
Xoma
Larry Jolivette
GlaxoSmithKline
Xing-Rong Liu
Pharmacokinetics,
Dynamics and Metabolism
Roche
Bimal Malhotra
Director, Global Clinical Pharmacology
Pfizer, Inc.
Donavon McConn, Ph.D.
Associate Director
Drug Metabolism & Pharmacokinetics
Theravance, Inc.
William Pardridge
Professor of Medicine
UCLA |
Gabriel A. Silva
Assistant Professor Depts of Bioengineering & Ophthalmology, and Neurosciences Program
University of California, San Diego
Sandra Visser
AstraZeneca R&D Södertälje
Yulia Vugmeyster
Wyeth
Hong Wan
AstraZeneca R&D
Diane Wang
Pfizer, Inc.
Harvey Wong
Drug Metabolism & Pharmacokinetics
Genentech, Inc.
Shinji Yamazaki, Ph.D.
Pharmacokinetics, Dynamics and Metabolism
La Jolla Laboratories
Pfizer Global R&D
Ophelia Yin
Novartis
Back to Top
|
| |
|
|
Jack Hoppin
Bioscan
Chang-Deng Hu
Assistant Professor
Medicinal Chemistry and Molecular Pharmacology
Purdue University |
Klaus Ley
Head, Division of Inflammation Biology
La Jolla Institute for Allergy & Immunology Adjunct Professor of Bioengineering
UCSD
Richard Margolin
Project Director Early Clinical Research and Experimental Medicine
Schering Plough
Back to Top
|
| |
|
|
Miriam Bibel
Novartis
Caifu Chen
Director Gene Expression &
Genotyping Assays R&D
Applied Biosystems
Jay M. Edelberg, M.D. Ph.D.
Bristol Myers Squibb |
Mark Mercola
Burnham Institute for Medical Research
Chunhui Xu
Group Leader
Geron
Back to Top
|
| |
|
|
Marilyn A. Apfel, Ph.D.
xFDA
Steve Bannister, Ph.D.
Consultant
Xcelience |
James Wood, Esq.
Partner
Reed Smith LLP
Sergio Garcia
Partner
Reed Smith LLP
Back to Top
|
| |
|
|
Lars Eckmann
Professor of Medicine
University of California, San Diego
Hergen Spits
University of Amsterdam
|
Jan Tornell
Global Director
AstraZeneca Transgenics
and Comparative Genomics
Back to Top
|
| |
|
|
Scott D. Bembenek
Computer Aided Drug Discovery
Johnson & Johnson Pharmaceutical R&D
Michael Korn, M.D.
Associate Professor
UCSF Comprehensive Cancer Center |
Jonathan Roth
Scientific Investigator, Pharmacology
Amylin Pharmaceuticals, Inc.
Back to Top
|
| |
|
|
Debraj GuhaThakurta
Merck & Co.
Brian A Dougherty
Pfizer |
Garret Hampton
Celgene
Andrew Su
Genomics Institute of the Novartis Research Foundation
Back to Top
|
| |
|
|
Helen Garside
Advanced Science and Technology Laboratory AstraZeneca
Peter Sartipy
Project Manager
Cellartis |
Yi Yang, Ph.D., DABT, Associate Research Investigator, Cellular and Molecular Toxicology, Abbott Laboratories
Back to Top
|
| |
|
|
John Crison, Ph.D.
Director of Life Sciences
Simulations Plus, Inc.
Reinhard Ebner
Avalon Pharmaceuticals , Inc.
|
Hovhannes Gukasyan
Pfizer Global R&D
Chad Stoner
Pharmacokinetics, Dynamics & Metabolism group
Pfizer Global R&D
Back to Top
|
| |
|
|
Matthew Bogyo
Assistant Professor
Dept of Pathology
Stanford University School of Medicine
Henry Rodriguez
Director, Clinical Proteomic
Technologies for Cancer
OTIR, NCI |
Jan E. Schnitzer
Scientific Director
Professor of Cellular & Molecular Biology
Director of Vascular Biology & Angiogenesis
Sidney Kimmel Cancer Center
Back to Top
|